The 11 As for Access to ORS & Zinc for Under-5 Diarrhoea Treatment

Access to essential medicines is seen as the key barrier to health in developing countries, by governments and corporates alike[1]. The pharmaceutical industry and those involved in delivering patient healthcare often frame the issues surrounding ‘access’ as three – or sometimes four –  ‘As for Access’. ColaLife has looked at models of patient access covering, […]